Medical Management of Inflammatory Bowel Disease in the New Millennium

By Lombardi Daniel A.   Feller Edward R.   Shah Samir A.  

Comprehensive Therapy, Vol. 28, Iss. 1, 2002-03 ,pp. : 39-49

Humana Press, Inc

Access to resources Recommend Favorite

Tacrolimus Therapy for Refractory Renal Allograft Rejection: Experience With Steroid Withdrawal

By Cronin D.C.   Bruce D.S.   Newell K.A.   Josephson M.A.   Millis J.M.   Piper J.B.   Ruebe M.   Kirby M.   Thistlethwaite J.R.   Woodle E.S.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 307-307

Elsevier

Access to resources Recommend Favorite

PPAR and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and Crohn's disease

By Wada K.   Nakajima A.   Blumberg R.S.  

Trends in Molecular Medicine, Vol. 7, Iss. 8, 2001-08 ,pp. : 329-331

Elsevier

Access to resources Recommend Favorite

Inflammatory bowel disease (Crohn's disease) in a Spanish patient with pars plana exudates: Report of a new case and review of the literature

By Gorroño-Echebarría Marina B.   Albarrán Fernando   Marcos Ama   Alvarez-Mon Melchor  

Ocular Immunology and Inflammation, Vol. 10, Iss. 1, 2002-03 ,pp. : 65-68

Informa Healthcare

Access to resources Recommend Favorite

Tacrolimus and new onset diabetes mellitus: the effect of steroid weaning

By Baran D.A.   Ashkar J.   Galin I.D.   Sandler D.   Segura L.   Courtney M.C.   Correa R.   Chan M.   Lansman S.L.   Spielvogel D.   Cheng J.   Gass A.L.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1711-1712

Elsevier

Access to resources Recommend Favorite